申请人:Yoshitomi Pharmaceutical Industries Ltd.
公开号:US04423052A1
公开(公告)日:1983-12-27
1,4-Dihydropyridine-3,5-dicarboxylic acid ester derivatives represented by the formula ##STR1## (wherein Ar.sup.1 and Ar.sup.2 are each the same or different and represent an aryl group; R.sup.1 represents a lower alkyl group; R.sup.2 and R.sup.3 are each the same or different and represent a lower alkyl or aralkyl group; n is 1 or 2; and R.sup.4 represents a lower alkyl) or the acid addition salts thereof. These compounds are useful as antihypertensive agents and as agents for treating the disturbances of cardiac or cerebral circulation.
由公式##STR1##表示的1,4-二氢吡啶-3,5-二羧酸酯衍生物(其中Ar.sup.1和Ar.sup.2各自相同或不同,代表芳基;R.sup.1代表较低的烷基;R.sup.2和R.sup.3各自相同或不同,代表较低的烷基或芳基烷基;n为1或2;R.sup.4代表较低的烷基)或其酸盐。这些化合物可用作降压药物,以及用于治疗心脏或脑循环紊乱的药物。